Where is SciClone headquartered?

SciClone is located in Foster City, CA.

Who invested in SciClone?

SciClone has 13 investors including Geekdom Fund And Geekdom Fund.

When was the last funding round for SciClone?

SciClone closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

sciclone.com

SciClone

SciClone differentiated therapies for oncology, infectious diseases and cardiovascular, urological, respiratory, and central nervous system disorders.

Business Model:

Revenue: $172M

Employees: 501-1,000

Rankings

Industries / Tags:

Pharmaceuticals & Biotechnology

Biotechnology

Health Care

Detailed SciClone Information

M&A Details

SciClone was acquired by GL Capital.
The acquisition happend on 2017-06-08.
Details of the transaction were not public

Acquirer

GL Capital

General Information

Geographic Data

Address: 950 Tower Ln

City: Foster City

State: CA

Zip: 94404

Country: US

Financial Info

Stage:

series unknown

Raised Last:

$134M

Raised Total:

$134M

Social

Crunchbase

Metrics

3,414,726Website Global Rank

4,247Website Monthly Traffic

Twitter Followers

Description

SciClone differentiated therapies for oncology, infectious diseases and cardiovascular, urological, respiratory, and central nervous system disorders.

Contact Phone:
+16503583456

Contact Email:

IPO Details

SciClone went public on 3/3/2021 on the Hong Kong Stock Exchange

Listed Exchange:
Hong Kong Stock Exchange

IPO Date:
3/3/2021

Ticker Symbol:
6600

IPO Price:
$2.423832982436236/share

Amount Raised:
$263M

Live

Opened: -/share

EBITDA	-
Total Cash	-
Total Debt	-
Total Revenue	-
Total Profit (Gross)	-
PE Ratio	-

Investments

Announced Date	Company	Transaction	Money Raised
12/2020	Ability Pharmaceuticals	Corporate Round	3M
12/2020	Ability Pharmaceuticals	Corporate Round	0

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
2/2021	Venture Round		$0	Grand View Capital IDG Capital Opportunity Fund Shanghai Pharmaceutical Grand View Capital IDG Capital Opportunity Fund Shanghai Pharmaceutical
3/2021	IPO		$279M
2/2021	Venture Round	4	$134M	Grand View Capital IDG Capital Opportunity Fund Shanghai Pharmaceutical Grand View Capital IDG Capital Opportunity Fund Shanghai Pharmaceutical

Acquisitions

Announced Date	Name	Price
4/2011	NovaMed Pharmaceuticals

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details